Takeda Told to Pay $1.3 Million in Actos Punitive Damages
This article is for subscribers only.
A jury ordered Takeda Pharmaceutical Co. to pay $1.3 million in punitive damages to a former teacher who argued the drugmaker’s Actos diabetes medicine caused his bladder cancer, in the company’s fifth loss in trials over the drug
Jurors in state court in Philadelphia deliberated more than two hours Friday before concluding that Osaka, Japan-based Takeda must pay the punitive award to John Kristufek for showing “reckless indifference” to his health by mishandling the diabetes drug.On Thursday, the same panel awarded Kristufek more than $2.3 million in compensatory damages.